[{"id":"231ac021-45b1-428b-af4d-b8baa99c2e26","acronym":"","url":"https://clinicaltrials.gov/study/NCT05123209","created_at":"2021-11-17T12:53:28.719Z","updated_at":"2024-07-02T16:36:20.577Z","phase":"Phase 1","brief_title":"Safety and Efficacy Evaluation of IM83 CAR-T Cells for Patients With Advanced Liver Tumors","source_id_and_acronym":"NCT05123209","lead_sponsor":"Beijing Immunochina Medical Science \u0026 Technology Co., Ltd.","biomarkers":" PD-L1 • PD-1 • GPC3","pipe":" | ","alterations":" GPC3 expression","tags":["PD-L1 • PD-1 • GPC3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GPC3 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IM83"],"overall_status":"Recruiting","enrollment":" Enrollment 12","initiation":"Initiation: 08/24/2021","start_date":" 08/24/2021","primary_txt":" Primary completion: 08/30/2023","primary_completion_date":" 08/30/2023","study_txt":" Completion: 08/30/2023","study_completion_date":" 08/30/2023","last_update_posted":"2021-11-17"},{"id":"7999af4d-c2dc-4a34-8953-971c61fe87f8","acronym":"","url":"https://clinicaltrials.gov/study/NCT04951141","created_at":"2021-07-06T12:52:58.378Z","updated_at":"2024-07-02T16:36:28.340Z","phase":"Phase 1","brief_title":"Clinical Study of Intratumoral Injection of CAR-T Cells in the Treatment of Advanced Liver Tumors","source_id_and_acronym":"NCT04951141","lead_sponsor":"Beijing Immunochina Medical Science \u0026 Technology Co., Ltd.","biomarkers":" GPC3","pipe":" | ","alterations":" GPC3 expression","tags":["GPC3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GPC3 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IM83"],"overall_status":"Recruiting","enrollment":" Enrollment 10","initiation":"Initiation: 01/01/2019","start_date":" 01/01/2019","primary_txt":" Primary completion: 09/30/2023","primary_completion_date":" 09/30/2023","study_txt":" Completion: 12/21/2023","study_completion_date":" 12/21/2023","last_update_posted":"2021-07-05"}]